表紙
市場調查報告書

照護現場(POC)葡萄糖檢驗的全球市場:各產品 - 規模,佔有率,趨勢,及市場區隔預測(2019年∼2025年)

Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Freestyle Lite, True Metrix), And Segment Forecasts, 2019 - 2025

出版商 Grand View Research, Inc. 商品編碼 917725
出版日期 內容資訊 英文 145 Pages
商品交期: 2-3個工作天內
價格
Back to Top
照護現場(POC)葡萄糖檢驗的全球市場:各產品 - 規模,佔有率,趨勢,及市場區隔預測(2019年∼2025年) Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Freestyle Lite, True Metrix), And Segment Forecasts, 2019 - 2025
出版日期: 2019年11月28日內容資訊: 英文 145 Pages
簡介

全球照護現場(POC)葡萄糖檢驗市場,2018年是60億1,783萬美金。該市場預計至2025年期間以2.82%的年複合成長率成長,2025年達到73記憶869萬美元的規模。

本報告提供全球全球照護現場(POC)葡萄糖檢驗市場的相關調查,市場規模及趨勢,各產品、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查方法

  • 市場區隔、範圍
  • 市場定義
  • 資訊採購
  • 資訊分析
  • 市場定式化及資料的視覺化
  • 資料檢驗、公開

第2章 摘要整理

第3章 調查方法

  • 資訊採購
  • 資料分析

第4章 市場變數,趨勢,及規模

  • 市場區隔、範圍
  • 各要因SWOT分析(政治,法律,經濟,技術性)
  • 產業分析:波特的五力分析
  • 開發平台分析

第5章 市場分析:各產品

  • 市場趨勢分析
  • Accu-Chek
  • Onetouch Verio Flex
  • i-STAT
  • FreeStyle Lite
  • Bayer CONTOUR 血糖監測系統
  • True Metrix
  • Accu-Chek Inform II
    • 支撐Accu-Chek Inform II使用的要素
  • StatStrip
    • 支撐StatStrip使用的要素

第6章 市場分析:各地區

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 新加坡
  • 南美
    • 巴西
    • 墨西哥
  • 中東、非洲
    • 南非
    • 沙烏地阿拉伯

第7章 競爭情形

  • 策略性架構
  • 市場參與企業的分類
  • 企業簡介
目錄
Product Code: GVR-4-68038-134-4

The global point-of-care glucose testing market size recorded a revenue of USD 6,017.83 million in 2018 and is expected to reach USD 7,308.69 million by 2025 growing at a CAGR of 2.82%, according to a new report by Grand View Research, Inc. An increase in the demand for point-of-care testing (POCT) has been witnessed in recent years. As compared to the conventional laboratory testing performed central lab settings, glucose POCT aids in performing effective diagnosis at the patient's bedside. Easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings.

The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism has propelled the point-of-care glucose testing market players to launch innovative glucose meters in the market. Various companies are investing in the development of needle-less blood glucose monitoring devices to offer painless management of diabetes in patients.

For instance, GlucoTrack - a product manufactured by Integrity Applications (Israel) performs quantification using electromagnetic, ultrasonic, and thermal waves in combination. In addition, Eversense is another painless glucose monitoring subcutaneous implant offered by Senseonics. This implant is able to quantify glucose levels in interstitial fluid when placed beneath the skin. This is followed by data transmission to show the results in real time.

The latest no-code monitoring systems help in minimizing the errors that occur due to incorrect entry of strip codes. Whereas, others are incorporating noble metals such as silver, gold, and platinum which effectively reduces the electrical noise further improving accuracy.

Further key findings from the study suggest:

  • Accu-Chek Inform II accounted for the largest revenue share in 2018 and is anticipated to maintain this trend throughout the forecast period
  • Bayer CONTOUR blood glucose monitoring system is set to grow with a CAGR of 5.5% from 2019-2025
  • In terms of volume, the i-STAT ranked above all owing to its multipurpose utility in the diagnostics industry
  • North America is the leading regional market due to the higher penetration of novel diagnostic techniques
  • Asia Pacific has registered the fastest growth rate owing to numerous untapped growth opportunities in diagnostics and ever-increasing prevalence of diabetes
  • A robust network of local manufacturers has significantly contributed to the revenue generated in this region Some of the key market participants are F. Hoffmann-La Roche Ltd., Abbott, LifeScan, Inc., and Nova Biomedical among others

Table of Contents

Chapter 1. Research Methodology

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources & third party perspectives
    • 1.3.4. Primary research
  • 1.4. Information Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

Chapter 3. Research Methodology

  • 3.1. Information procurement
  • 3.2. Data Analysis

Chapter 4. Point-of-Care Glucose Testing Market Variables, Trends & Scope

  • 4.1. Market Segmentation & Scope
    • 4.1.1. Market driver analysis
      • 4.1.1.1. Introduction of CLIA waived tests
      • 4.1.1.2. Growing prevalence of diabetes
      • 4.1.1.3. Rising demand for short turnaround time glucose POC testing
    • 4.1.2. Market restraint analysis
      • 4.1.2.1. Potential interference and calibration issues in glucose meters
      • 4.1.2.2. Presence of ambiguous regulatory as well as reimbursement framework for primary care setting
  • 4.2. Point-of-care diagnostics SWOT analysis, by factor (Political & legal, economic, and technological)
  • 4.3. Industry Analysis - Porter's
  • 4.4. Pipeline Analysis
    • 4.4.1. Product pipeline by Phase
    • 4.4.2. Pipeline glucose meters; 2017
    • 4.4.3. Product pipeline by Applicant

Chapter 5. Point-of-Care Glucose Testing Market Categorization: Product Estimates & Trend Analysis

  • 5.1 Global Glucose Point-of-Care Diagnostics/Testing Market: Product Movement Analysis
  • 5.2 Accu-Chek
    • 5.2.1 Accu Check Aviva meter market revenue, 2014 - 2025 (USD Million)
    • 5.2.2 Accu Check Aviva meter market volume, 2014 - 2025 (Thousand Units)
  • 5.3 Onetouch Verio Flex
    • 5.3.1 Onetouch Verio Flex market revenue, 2014 - 2025 (USD Million)
    • 5.3.2 Onetouch Verio Flex market volume, 2014 - 2025 (Thousand Units)
  • 5.4 i-STAT
    • 5.4.1 i-STAT market revenue, 2014 - 2025 (USD Million)
    • 5.4.2 i-STAT market volume, 2014 - 2025 (Thousand Units)
  • 5.5 FreeStyle Lite
    • 5.5.1 FreeStyle Lite market revenue, 2014 - 2025 (USD Million)
    • 5.5.2 FreeStyle Lite market volume, 2014 - 2025 (Thousand Units)
  • 5.6 Bayer CONTOUR Blood Glucose Monitoring System
    • 5.6.1 Bayer CONTOUR blood glucose monitoring system market revenue, 2014 - 2025 (USD Million)
    • 5.6.2 Bayer CONTOUR blood glucose monitoring system market volume, 2014 - 2025 (Thousand Units)
  • 5.7 True Metrix
    • 5.7.1 True Metrix market revenue, 2014 - 2025 (USD Million)
    • 5.7.2 True Metrix market volume, 2014 - 2025 (Thousand Units)
  • 5.8 Accu-Chek Inform II
    • 5.8.1 Factors favouring the usage of Accu-Chek Inform II
    • 5.8.2 Accu-Chek Inform II market revenue, 2014 - 2025 (USD Million)
    • 5.8.3 Accu-Chek Inform II market volume, 2014 - 2025 (Thousand Units)
  • 5.9 StatStrip
    • 5.9.1 Factors favouring the usage of StatStrip
    • 5.9.2 StatStrip market revenue, 2014 - 2025 (USD Million)
    • 5.9.3 StatStrip market volume, 2014 - 2025 (Thousand Units)

Chapter 6. Point-of-Care Glucose Testing Market Categorization: Regional Estimates & Trend Analysis

  • 6.1 North America
    • 6.1.1 North America point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
    • 6.1.2 North America point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.1.3 U.S.
      • 6.1.3.1 U.S. point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.1.3.2 U.S. point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.1.4 Canada
      • 6.1.4.1 Canada point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.1.4.2 Canada point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • 6.2 Europe
    • 6.2.1 Europe point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
    • 6.2.2 Europe point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.2.3 Germany
      • 6.2.3.1 Germany point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.2.3.2 Germany point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.2.4 UK
      • 6.2.4.1 UK point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.2.4.2 UK point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.2.5 France
      • 6.2.5.1 France point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.2.5.2 France point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.2.6 Italy
      • 6.2.6.1 Italy point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.2.6.2 Italy point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.2.7 Spain
      • 6.2.7.1 Spain point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.2.7.2 Spain point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.2.8 Russia
      • 6.2.8.1 Russia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.2.8.2 Russia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • 6.3 Asia Pacific
    • 6.3.1 Asia Pacific point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
    • 6.3.2 Asia Pacific point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.3.3 Japan
      • 6.3.3.1 Japan point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.3.3.2 Japan point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.3.4 China
      • 6.3.4.1 China point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.3.4.2 China point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.3.5 India
      • 6.3.5.1 India point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.3.5.2 India point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.3.6 Australia
      • 6.3.6.1 Australia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.3.6.2 Australia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.3.7 Korea
      • 6.3.7.1 Korea point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.3.7.2 Korea point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.3.8 Singapore
      • 6.3.8.1 Singapore point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.3.8.2 Singapore point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • 6.4 Latin America
    • 6.4.1 Latin America point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
    • 6.4.2 Latin America point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.4.3 Brazil
      • 6.4.3.1 Brazil point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.4.3.2 Brazil point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.4.4 Mexico
      • 6.4.4.1 Mexico point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.4.4.2 Mexico point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • 6.5 Middle East & Africa.
    • 6.5.1 Middle East & Africa point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
    • 6.5.2 Middle East & Africa point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.5.3 South Africa
      • 6.5.3.1 South Africa point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.5.3.2 South Africa point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.5.4 Saudi Arabia
      • 6.5.4.1 Saudi Arabia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.5.4.2 Saudi Arabia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)

Chapter 7. Competitive Landscape

  • 7.1. Strategy Framework
  • 7.2. Market Participation Categorization
  • 7.3. Company Profiles
    • 7.3.1. F. Hoffmann-La Roche Ltd.
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Product benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. Abbott
      • 7.3.2.1. Company overview
      • 7.3.2.2. Alere
      • 7.3.2.2.1. Company overview
      • 7.3.2.3. Financial performance
      • 7.3.2.3.1. Financial performance
      • 7.3.2.4. Product benchmarking
      • 7.3.2.5. Strategic initiatives
    • 7.3.3. Nipro
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
    • 7.3.4. Platinum Equity, LLC. (LifeScan, Inc.)
      • 7.3.4.1. Company overview
      • 7.3.4.2. Product benchmarking/Product portfolio
      • 7.3.4.3. Strategic initiatives
    • 7.3.5. Nova Biomedical
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking/Product portfolio
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. ACON Laboratories, Inc.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking/Product portfolio
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Trividia Health, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking/Product portfolio
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Prodigy Diabetes Care, LLC.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Product benchmarking/Product portfolio
    • 7.3.9. Bayer AG/Ascensia Diabetes Care Holdings AG
      • 7.3.9.1. Company overview
      • 7.3.9.2. Product benchmarking/Product portfolio
      • 7.3.9.3. Financial performance
    • 7.3.10. EKF Diagnostics
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking

List of Tables

  • TABLE 1 Examples: CLIA waived tests
  • TABLE 2 North America diabetes prevalence (National prevalence %), 2013 & 2035
  • TABLE 3 Europe diabetes prevalence (National prevalence %), 2013 & 2035
  • TABLE 4 Asia Pacific diabetes prevalence (National prevalence %), 2013 & 2035
  • TABLE 5 Latin America diabetes prevalence (National prevalence %), 2013 & 2035
  • TABLE 6 MEA and Africa diabetes prevalence (National prevalence %), 2013 & 2035
  • TABLE 7 CIS diabetes prevalence (National prevalence %), 2013 & 2035
  • TABLE 8 Specifications of Accu-Chek
  • TABLE 9 Specifications of Accu-Chek Guide Me meter
  • TABLE 10 Specifications of Accu-Chek Aviva meter
  • TABLE 11 Specifications of Accu-Chek Aviva meter
  • TABLE 12 Specifications of Accu-Chek Nano meter
  • TABLE 13 Specifications of OneTouch Verio Flex meter
  • TABLE 14 Specifications of i-STAT analyser
  • TABLE 15 Specifications of FreeStyle Lite system
  • TABLE 16 Specifications of Bayer CONTOUR meter
  • TABLE 17 Specifications of TRUE METRIX
  • TABLE 18 Features and properties of ACCU-CHEK INFORM II
  • TABLE 19 Specifications of STATSTRIP
  • TABLE 20 STATSTRIP: Improved Sensitivity for Detecting Hypoglycemia
  • TABLE 21 Significant decline in deaths caused by StatStrip
  • TABLE 22 Glucose meter offered by One Drop
  • TABLE 23 HemoCue AB: Glucose POC diagnostics
  • TABLE 24 Dexcom glucose testing products marketed in France
  • TABLE 25 Some of the local glucose POC testing manufacturers in China
  • TABLE 26 Some of the local glucose POC testing manufacturers in India
  • TABLE 27 Primary guidelines for glucose POC testing in Australia
  • TABLE 28 Prevalence of diabetes and related risk factors; 2016
  • TABLE 29 Availability of basic technologies in the Brazilian primary care facilities

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Point-of-care diagnostics: Market trends & outlook
  • FIG. 8 Market segmentation & scope
  • FIG. 9 Glucose point-of-care diagnostics/testing market: Driver relevance analysis (Current & future impact)
  • FIG. 10 Shift in POC molecular diagnostic trends
  • FIG. 11 Current and projected prevalence of diabetes, by geography, 2013 & 2035 (%)
  • FIG. 12 Schematic representation of POCT device connectivity
  • FIG. 13 Point of care diagnostics market: Restraint relevance analysis (Current & future impact)
  • FIG. 14 Point-of-care diagnostics: SWOT analysis, by factor (Political & legal, economic, and technological)
  • FIG. 15 Point-of-care diagnostics: Porter's five forces analysis
  • FIG. 16 Glucose point-of-care diagnostics market product outlook key takeaways
  • FIG. 17 Accu Check Aviva meter market revenue, 2014 - 2025 (USD Million)
  • FIG. 18 Accu Check Aviva meter market volume, 2014 - 2025 (Thousand Units)
  • FIG. 19 Onetouch Verio Flex market revenue, 2014 - 2025 (USD Million)
  • FIG. 20 Onetouch Verio Flex market volume, 2014 - 2025 (Thousand Units)
  • FIG. 21 i-STAT market revenue, 2014 - 2025 (USD Million)
  • FIG. 22 i-STAT market volume, 2014 - 2025 (Thousand Units)
  • FIG. 23 FreeStyle Lite market revenue, 2014 - 2025 (USD Million)
  • FIG. 24 FreeStyle Lite market volume, 2014 - 2025 (Thousand Units)
  • FIG. 25 Bayer CONTOUR blood glucose monitoring system market revenue, 2014 - 2025 (USD Million)
  • FIG. 26 Bayer CONTOUR blood glucose monitoring system market volume, 2014 - 2025 (Thousand Units)
  • FIG. 27 True Metrix market revenue, 2014 - 2025 (USD Million)
  • FIG. 28 True Metrix market volume, 2014 - 2025 (Thousand Units)
  • FIG. 29 Accu-Chek Inform II market revenue, 2014 - 2025 (USD Million)
  • FIG. 30 Accu-Chek Inform II market volume, 2014 - 2025 (Thousand Units)
  • FIG. 31 StatStrip market revenue, 2014 - 2025 (USD Million)
  • FIG. 32 StatStrip market volume, 2014 - 2025 (Thousand Units)
  • FIG. 33 Regional market place: Key takeaways
  • FIG. 34 North America point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 35 North America point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 36 U.S. point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 37 U.S. point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 38 Canada point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 39 Canada point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 40 Europe point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 41 Europe point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 42 Germany point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 43 Germany point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 44 UK point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 45 UK point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 46 France point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 47 France point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 48 Italy point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 49 Italy point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 50 Spain point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 51 Spain point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 52 Russia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 53 Russia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 54 Asia Pacific point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 55 Asia Pacific point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 56 Japan point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 57 Japan point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 58 China point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 59 China point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 60 India point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 61 India point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 62 Australia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 63 Australia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 64 Korea point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 65 Korea point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 66 Singapore point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 67 Singapore point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 68 Latin America point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 69 Latin America point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 70 Brazil point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 71 Brazil point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 72 Mexico point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 73 Mexico point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 74 Middle East & Africa point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 75 Middle East & Africa point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 76 South Africa point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 77 South Africa point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 78 Saudi Arabia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 79 Saudi Arabia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 80 Strategy framework
  • FIG. 81 Participant categorization
Back to Top